Diego O Croci
Diego O Croci
Investigador Adjunto IHEM-CONICET
Verified email at - Homepage
Cited by
Cited by
Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death
MA Toscano, GA Bianco, JM Ilarregui, DO Croci, J Correale, ...
Nature immunology 8 (8), 825-834, 2007
Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors
DO Croci, JP Cerliani, T Dalotto-Moreno, SP Méndez-Huergo, ...
Cell 156 (4), 744-758, 2014
Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10
JM Ilarregui, DO Croci, GA Bianco, MA Toscano, M Salatino, ...
Nature immunology 10 (9), 981-991, 2009
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration
SC Starossom, ID Mascanfroni, J Imitola, L Cao, K Raddassi, ...
Immunity 37 (2), 249-263, 2012
Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer
GA Rabinovich, DO Croci
Immunity 36 (3), 322-335, 2012
Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease
T Dalotto-Moreno, DO Croci, JP Cerliani, VC Martinez-Allo, ...
Cancer research 73 (3), 1107-1117, 2013
Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment
DO Croci, MF Zacarías Fluck, MJ Rico, P Matar, GA Rabinovich, ...
Cancer immunology, immunotherapy 56, 1687-1700, 2007
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
DO Croci, M Salatino, N Rubinstein, JP Cerliani, LE Cavallin, HJ Leung, ...
Journal of Experimental Medicine 209 (11), 1985-2000, 2012
A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease
DJ Laderach, LD Gentilini, L Giribaldi, VC Delgado, L Nugnes, DO Croci, ...
Cancer research 73 (1), 86-96, 2013
Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem‐repeat” lectin galectin‐8
VMC Delgado, LG Nugnes, LL Colombo, MF Troncoso, MM Fernández, ...
The FASEB Journal 25 (1), 242-254, 2011
Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function
LA Pasquini, V Millet, HC Hoyos, JP Giannoni, DO Croci, M Marder, ...
Cell Death & Differentiation 18 (11), 1746-1756, 2011
Fucans, but Not Fucomannoglucuronans, Determine the Biological Activities of Sulfated Polysaccharides from Laminaria saccharina Brown Seaweed
DO Croci, A Cumashi, NA Ushakova, ME Preobrazhenskaya, A Piccoli, ...
PLoS One 6 (2), e17283, 2011
Translating the ‘sugar code’into immune and vascular signaling programs
JP Cerliani, AG Blidner, MA Toscano, DO Croci, GA Rabinovich
Trends in biochemical sciences 42 (4), 255-273, 2017
Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer
M Salatino, DO Croci, GA Bianco, JM Ilarregui, MA Toscano, ...
Expert opinion on biological therapy 8 (1), 45-57, 2008
The immunoregulatory glycan‐binding protein galectin‐1 triggers human platelet activation
N Pacienza, RG Pozner, GA Bianco, LP D'Atri, DO Croci, S Negrotto, ...
The FASEB Journal 22 (4), 1113-1123, 2008
Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity?
MA Toscano, JM Ilarregui, GA Bianco, L Campagna, DO Croci, M Salatino, ...
Cytokine & growth factor reviews 18 (1-2), 57-71, 2007
Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues
V Sundblad, DO Croci Russo, GA Rabinovich
F Hernandez, 2011
Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression
LE Rossi, DE Avila, RG Spallanzani, A Ziblat, MB Fuertes, L Lapyckyj, ...
Journal of leukocyte biology 91 (2), 321-331, 2012
Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells
AJ Cagnoni, ML Giribaldi, AG Blidner, AM Cutine, SG Gatto, RM Morales, ...
Proceedings of the National Academy of Sciences 118 (21), e2102950118, 2021
Targeting galectin-driven regulatory circuits in cancer and fibrosis
KV Mariño, AJ Cagnoni, DO Croci, GA Rabinovich
Nature Reviews Drug Discovery 22 (4), 295-316, 2023
The system can't perform the operation now. Try again later.
Articles 1–20